Next Article in Journal
Formulation and Evaluation of Diltiazem Hydrochloride Gels for the Treatment of Anal Fissures
Previous Article in Journal
Development and Characterization of New Indomethacin Self-Nanoemulsifying Formulations
Article Menu

Article Versions

Export Article

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessArticle
Sci. Pharm. 2009, 77(2), 453-464;

Preparation and In Vitro Evaluation of a Pegylated Nano-Liposomal Formulation Containing Docetaxel

Novel Drug Delivery Systems Lab., Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, PO Box 14155-6451, Iran
Research and Development Dept., Sobhan Oncology Company, Rasht, Iran
Medical Nanotechnology Research Centre, Tehran University of Medical Sciences, Tehran, Iran
Author to whom correspondence should be addressed.
Received: 9 June 2008 / Accepted: 18 March 2009 / Published: 19 March 2009
PDF [319 KB, uploaded 21 December 2016]


An improved pegylated liposomal formulation of docetaxel has been developed with the purpose of improving the docetaxel solubility without any need to use tween80 that is responsible for hypersensitivities following administration. Liposomes all had spherical shape with size of 130–160 nm. The most important finding of this study is that pegylated liposomes were prepared with significant increase in docetaxel encapsulation efficiency and stability of the formulation in comparison with last reports on docetaxel liposomes. In vitro release studies revealed that such a formulation could be stable in the blood circulation and meet the requirements for an effective drug delivery system.
Keywords: Docetaxel; Liposome; Stability; Pegylated; Nanoparticle Docetaxel; Liposome; Stability; Pegylated; Nanoparticle
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

YOUSEFI, A.; ESMAEILI, F.; RAHIMIAN, S.; ATYABI, F.; DINARVAND, R. Preparation and In Vitro Evaluation of a Pegylated Nano-Liposomal Formulation Containing Docetaxel. Sci. Pharm. 2009, 77, 453-464.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top